For employers and health plans, this translates into improved adherence, reduced discontinuation, and better clinical and financial outcomes
We solicited comment on our proposal to require that the lookback period for the median allowed amount, the 10th and 90th percentile allowed amounts, and count of allowed amounts be based on EDI 835 ERA transaction data from no longer than 12 months prior to posting the MRF
In a world where quick fixes often disappoint, its refreshing to see both modern medicine (GLP-1s) and traditional plant compounds (berberine) coming together
Sadly, these meds can be incredibly expensive, depending on the brand and whether or not you have insurance
the "PDA counterion argument" for regulatory compliance has not been validated by FDA guidance as of April 2026
A dose-dependent increase in hepatocyte cytotoxicity was not detected after 4 h of ITZ exposure using calcein AM or MTT assays